Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of inducing immunity against SARS-CoV-2 using spike (s) and nucleocapsid (N)-ETSD immunogens delivered by a replication-defective adenovirus

Method of inducing immunity against SARS-CoV-2 using spike (s) and nucleocapsid (N)-ETSD immunogens delivered by a replication-defective adenovirus

US Patent 11857620 · Granted Jan 2, 2024

Estimated economic value: $114,817,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods and systems for separating metals2025
Curation and provision of digital content2025
Distributed command execution in multi-location studio environments2025
Conditional modulation of therapy using recombinant cells2025
Location indexed blockchains, systems and method2025
Distributed storage systems and methods2025
Latency management in an event driven gaming network2025
Fine grained network management to edge device features2025
Maximizing T-cell memory and compositions and methods therefor2025
Maximizing T-cell memory and compositions and methods therefor2025
Modified NK-92 haNK003 cells for the clinic2025
Sixty gigahertz wireless communication systems2025